Filter posts

Making Sense and Cents Out of Pharma Strategic Venture Investing

For most large pharmaceutical companies, strategic venture arms are no longer a “nice to have,” …

Unleashing CAR-T Therapies on Solid Tumors: Are We There Yet?

Chimeric antigen receptor (CAR) T cell therapies have shown dramatic results against certain blood cancers …

Tchotchke’s Abound at BIO2017

BIO2107 is filled with partnering meetings, great sessions, motivating fireside chats and a trade show …

“CEPI: A New Approach to Vaccine Funding and Innovation for Emerging Infectious Diseases”

Tuesday morning of the 2017 BIO International Convention commenced the Infectious Diseases & Vaccines Track …

Panel Takes Look at Trump’s Trade Policy

Day three of the BIO International Convention brought some heavy hitters to the stage. From …

Invest in Diversity to Drive Innovation

“We’re just looking for someone with the right ‘fit.’”  How many times have you heard …

U.S. Department of Defense Officials Introduce New Strategies to Stimulate Medical Countermeasures D...

For the past several years, BIO has had the opportunity to partner with the U.S. …

Start-Up CEO: Making the Choices to Develop a Novel Medicine

The choices surrounding research investment and drug development are daunting for even the most experienced …

On Drug Costs, “We All have Accountability and Responsibility”

The BIO 2017 convention is well underway, highlighting the innovative breakthroughs taking place across the …

BIO2017: Tuesday’s Exhibit Show Floor Finds

  With over 1,800 exhibitors at BIO2017, there is truly something for everyone.  From a …